Procter Gamble Drc Stock Current Valuation

PG Stock  ARS 12,425  200.00  1.64%   
Valuation analysis of Procter Gamble DRC helps investors to measure Procter Gamble's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
12,425
Please note that Procter Gamble's price fluctuation is very steady at this time. Calculation of the real value of Procter Gamble DRC is based on 3 months time horizon. Increasing Procter Gamble's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Procter Gamble is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Procter Stock. However, Procter Gamble's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  12425.0 Real  10799.24 Hype  12425.0
The real value of Procter Stock, also known as its intrinsic value, is the underlying worth of Procter Gamble DRC Company, which is reflected in its stock price. It is based on Procter Gamble's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Procter Gamble's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
10,798
Downside
10,799
Real Value
13,668
Upside
Estimating the potential upside or downside of Procter Gamble DRC helps investors to forecast how Procter stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Procter Gamble more accurately as focusing exclusively on Procter Gamble's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
12,42412,42512,426
Details

Procter Gamble DRC Company Current Valuation Analysis

Procter Gamble's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Procter Gamble Current Valuation

    
  66.88 T  
Most of Procter Gamble's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Procter Gamble DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Procter Gamble DRC has a Current Valuation of 66.88 T. This is much higher than that of the Consumer Defensive sector and significantly higher than that of the Household & Personal Products industry. The current valuation for all Argentina stocks is significantly lower than that of the firm.

Procter Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Procter Gamble's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Procter Gamble could also be used in its relative valuation, which is a method of valuing Procter Gamble by comparing valuation metrics of similar companies.
Procter Gamble is rated below average in current valuation category among its peers.

Procter Fundamentals

About Procter Gamble Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Procter Gamble DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procter Gamble using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procter Gamble DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Procter Stock

Procter Gamble financial ratios help investors to determine whether Procter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procter with respect to the benefits of owning Procter Gamble security.